Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2012
08/23/2012US20120214739 Fgf variants and methods for use thereof
08/23/2012US20120214738 Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases
08/23/2012US20120214737 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by nrg-2
08/23/2012US20120214736 Compositions and methods for the modulation of jnk proteins
08/23/2012US20120214735 Acetamide derivatives as glucokinase activators, their process and medicinal applications
08/23/2012US20120214734 Treatment of metabolic disorders
08/23/2012US20120214733 Oxytocin receptor agonists
08/23/2012US20120214732 Inhibitors of the Trypsin-Like Site of the Proteasome and Methods of Use Thereof
08/23/2012US20120214731 Compound ws 727713
08/23/2012US20120214730 Method of using heparin binding motif for treating asthma
08/23/2012US20120214729 Composition for preventing or treating inflammation
08/23/2012US20120214728 Ex vivo and in vivo methods and related compositions for regenerating hematopoietic stem cell populations
08/23/2012US20120214687 Baff receptor (bcma), an immunoregulatory agent
08/23/2012US20120214233 Cystatin c as an antagonist of tgf-beta and methods related thereto
08/23/2012US20120214206 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
08/23/2012US20120214196 Polypeptides Having Glucoamylase Activity And Polynucleotides Encoding Same
08/23/2012US20120213857 Method for Producing Pancreatin Pellets
08/23/2012US20120213846 Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
08/23/2012US20120213845 Skin composition comprising an exfoliate, a brightener and a collagen booster, and method of using the same
08/23/2012US20120213843 Composition for promoting wound healing
08/23/2012US20120213834 Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
08/23/2012US20120213829 Dry powder aerosols of nanoparticulate drugs
08/23/2012US20120213826 Use of Pro-Inflammatory Compounds for Promoting Bone Formation
08/23/2012US20120213809 Vault complexes for cytokine delivery
08/23/2012US20120213808 Carbonic anhydrase i serving as novel antigen to be used for treatment of autoimmune diseases
08/23/2012US20120213807 Neprilysin inhibitors
08/23/2012US20120213806 Neprilysin inhibitors
08/23/2012US20120213802 PAR-1 Antagonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections
08/23/2012US20120213801 Phosphorylated Twist1 and cancer
08/23/2012US20120213795 Compositions and methods for inhibition of the jak pathway
08/23/2012US20120213790 Methods of treatment using il-16 antagonist peptides
08/23/2012US20120213782 Bmp10 antibodies and related methods
08/23/2012US20120213781 Monovalent and Multivalent Multispecific Complexes and Uses Thereof
08/23/2012US20120213777 Vascular endothelial growth factor 2
08/23/2012US20120213773 Binding domain-immunoglobulin fusion proteins
08/23/2012US20120213769 Methods of diagnosing amyotrophic lateral sclerosis (als)
08/23/2012US20120213768 Diagnostic and Therapeutic Uses for B Cell Maturation Antigen
08/23/2012US20120213767 Extended Soluble PH20 Polypeptides and uses thereof
08/23/2012US20120213766 Anticancer Compounds from Vernonia Guineensis
08/23/2012US20120213764 Novel method for the production of a antimicrobial peptide
08/23/2012US20120213763 Mutants of streptokinase and their covalently modified forms
08/23/2012US20120213762 Lysosomal targeting peptides and uses thereof
08/23/2012US20120213761 Use of gstp1
08/23/2012US20120213760 Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularin 1(mtm1) polypeptides
08/23/2012US20120213757 Nutritional supplement composition
08/23/2012US20120213756 Nutraceutical beverage
08/23/2012US20120213755 Semi-synthetic platelet gel and method for the preparation thereof
08/23/2012US20120213752 Isolated stromal cells and methods of using the same
08/23/2012US20120213744 Compositions and methods for modulating stem cells and uses thereof
08/23/2012US20120213738 Cardiac Repair By Reprogramming of Cardiac Fibroblasts Into Cardiomyocytes
08/23/2012US20120213737 Compositions and methods for therapeutic membrane repair
08/23/2012US20120213736 Parvovirus methods and compositions for killing neoplastic cells
08/23/2012US20120213735 Therapeutic furopyrimidines and thienopyrimidines
08/23/2012US20120213734 Method for Cancer Therapy Based on a Co-Administration of a Parvovirus and a Cytokine
08/23/2012US20120213733 Anti-infective agents and uses thereof
08/23/2012US20120213731 Methods and compositions for treating autoimmune diseases
08/23/2012US20120213730 Alteration of cell membrane for new functions
08/23/2012US20120213729 Compounds for the Treatment of Hepatitis C
08/23/2012US20120213728 Granulocyte-colony stimulating factor produced in glycoengineered pichia pastoris
08/23/2012US20120213697 Versatile nanoparticulate biomaterial for controlled delivery and/or containment of therapeutic and diagnostic material
08/23/2012US20120210547 Immunoneutral silk-fiber-based medical devices
08/23/2012DE102011004335A1 Verfahren zur Herstellung eines Vakzins A process for the preparation of a vaccine
08/23/2012CA2827301A1 Compositions and methods for the therapy and diagnosis of influenza
08/23/2012CA2827006A1 Wild-type apolipoprotein l-i for use in the prevention of kidney diseases
08/23/2012CA2826683A1 Hsa-related compositions and methods of use
08/23/2012CA2823721A1 Compositions, devices and methods of use thereof for the treatment of cancers
08/23/2012CA2810334A1 Methods and compositions relating to coagulation assays
08/22/2012EP2489731A1 Modified lecithin-cholesterol acyltransferase enzymes
08/22/2012EP2489730A1 Modified lecithin-cholesterol acyltransferase enzymes
08/22/2012EP2489669A1 Haprolid and derivatives thereof as inhibitors of HCV
08/22/2012EP2489366A1 Use of spink6 gene and protein encoded therein in the manufacture of anti-tumor medicaments
08/22/2012EP2489365A1 Wild-type apolipoprotein L-I for use in the prevention of kidney diseases
08/22/2012EP2489364A1 Monomethylvaline compounds onjugated to antibodies
08/22/2012EP2489363A2 Agonist peptides of basic fibroblast growth factor (BFGF) and the method of reduction of wrinkle on skin, darkening of hair and acceleration of wound healing
08/22/2012EP2489362A1 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
08/22/2012EP2489361A1 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases
08/22/2012EP2489360A1 Stabilized MAML peptides and uses thereof
08/22/2012EP2489359A1 Fat accumulation suppressor
08/22/2012EP2489349A2 Pancreatin pellets, in particular pancreatin micropellets and method for producing same
08/22/2012EP2489348A1 Pharmaceutical composition containing medicament-containing fine particles and method for producing same
08/22/2012EP2489346A1 Food supplement and injectable material for prophylaxis and therapy of osteoporosis and other bone diseases
08/22/2012EP2489338A1 Dry wound dressing and drug delivery system
08/22/2012EP2488643A1 Chimeric fibroblast growth factors with altered receptor specificity
08/22/2012EP2488637A1 Inhibitors of phosphatase and tensin homolog (pten) compositions, uses and methods
08/22/2012EP2488550A2 Mutant low-density lipoprotein receptor related protein with increased binding to alzheimer amyloid-beta peptide
08/22/2012EP2488256A1 Na-k pump modulation
08/22/2012EP2488208A1 Compounds having peptides conjugated to bone targeting moieties and methods of making and using thereof
08/22/2012EP2488207A2 Polymeric systems for the delivery of anticancer agents
08/22/2012EP2488198A2 Treatment and diagnosis of inflammatory disorders
08/22/2012EP2488195A2 Neuropeptide-2 receptor (y-2r) agonists
08/22/2012EP2488194A2 Use of a neuregulin to treat peripheral nerve injury
08/22/2012EP2488193A1 Improved peptidomimetic macrocycles
08/22/2012EP2488192A1 Combinations of a specific hcv ns5a inhibitor and an hcv ns3 protease inhibitor
08/22/2012EP2488191A1 Enteral administration of arginine-glutamine dipeptide to support retinal, intestinal, or nervous system development
08/22/2012EP2488190A1 Reducing the risk of pathological effects of traumatic brain injury
08/22/2012EP2488044A1 Allergy treatment using acid treated aqueous whey protein extract
08/22/2012EP2298338B1 Lactoferrin compositions and methods of treatment of skin wounds
08/22/2012EP2175834B8 Glp-1-fc fusion protein formulation
08/22/2012EP2156820B1 Skin whitening agent
08/22/2012EP2061485B1 EV576 peptides for use in the treatment of Guillain Barré syndrome
1 ... 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 ... 3163